Publication | Open Access

Milvexian, an orally bioavailable, small‐molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits

ThrombosisDirect InhibitorBlood PlateletMedicineHematologyHemostasisVascular BiologyPharmacotherapyPharmacologyAnticoagulantExperimental ThrombosisFactor Xia